Avantor, Inc.
AVTRHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframePart of the healthcare sector, Avantor, Inc. (AVTR) is listed under Medical Instruments & Supplies. Valued at $6.25B, AVTR is a mid-cap name in its sector. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips.
Market Cap
$6.25B
Beta
0.94
P/E (TTM)
—
P/E (Fwd)
10.74
EPS (TTM)
$-0.81
EPS (Fwd)
$0.85
ROE
-9.4%
ROA
2.8%
Cash
$279.3M
Total Debt
$3.82B
Free CF
$489.4M
52W Change
-29.1%
Annual Financials
Cash vs Debt
On the balance sheet, AVTR has $279.3M in cash with $3.82B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $489.4M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of -9.4% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 2.8% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $7.51B (2022) to $6.55B (2025), a 13% decline worth watching.
The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Avantor, Inc.'s trajectory.